2020: The company is sold to Sanofi for $3.7 billion
In August, 2020 the French pharmaceutical company Sanofi agreed about purchase of the American Principia Biopharma Inc approximately for $3.7 billion.
According to a joint statement, Sanofi will take the shares of Principia which are in circulation for $ dollars 100 for paper money. The aggregate value of the company will be about $3.68 billion on completely watered basis, and an award to Principia Biopharma share price in $90.74 for the moment of closing of biddings on August 14 - 10%.
Sanofi reported that acquisition of Principia Biopharma which develops methods of treatment of a serious immune illness will strengthen the research capacity of the company in such areas as autoimmune and allergic diseases.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |